Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what clinical trials underway in (a) the UK and (b) elsewhere in the world the Government is monitoring for the purposes of assessing the effectiveness of ivermectin as a treatment for covid-19; and what the timeframes are for the reporting of those trials.

The Department is closely monitoring the evidence on the case for ivermectin as a treatment for COVID-19. On 23 June, the PRINCIPLE clinical trial platform announced that ivermectin would be investigated to generate robust data on its effectiveness in treating adults aged 18 years old and over who are at higher risk of serious illness from COVID-19. We will closely monitor the data from this trial, as well as emerging clinical trials worldwide to expand our evidence-base on the efficacy of ivermectin. We expect that data will become available from trials throughout 2021 and 2022 and will be reviewed by the Medicines and Healthcare products Regulatory Agency.